Pulse Explore Journal Club Debates Trending Researchers Journals

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Home Explore Journal Club Trending

⌘+K

Disease models and AAV therapies of PKP2-induced arrhythmogenic cardiomyopathy | Synapse

February 28, 2026Molecular Therapy Advances0 citationsOpen Access

View Full Paper

Disease models and AAV therapies of PKP2-induced arrhythmogenic cardiomyopathy

LGLotte Geerlings YCYago Rodriguez Carreras MVM. Vermeer

Key Points

Key points are not available for this paper at this time.

Ask AI

Helpful

Bookmark

Share

View Full Paper

Cite This Study

Geerlings et al. (Mon,) studied this question.

synapsesocial.com/papers/6a025a5a9cddff7633412b84 https://doi.org/https://doi.org/10.1016/j.omta.2026.201688

Ask AI

Helpful

Bookmark

Share

View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The role of mouse strain differences in the susceptibility to fibrosis: a systematic review2013 · 162 citations
2Protein Binding and Functional Characterization of Plakophilin 22002 · 232 citations
3Emerging Issues in AAV-Mediated In Vivo Gene Therapy2017 · 878 citations
4Cardiac mesenchymal stromal cells are a source of adipocytes in arrhythmogenic cardiomyopathy2015 · 99 citations
5Loss of plakophilin 2 disrupts heart development in zebrafish2012 · 27 citations